Hermetica Superfood Encyclopedia
The Short Answer
Muru pungu seeds contain bufotenin (5-HO-DMT, up to 7.4% by dry weight), DMT, and 5-MeO-DMT, all of which act as serotonin 5-HT2A receptor agonists producing potent psychoactive and vasoconstrictive effects. No controlled clinical trials have evaluated its reported wound-healing use in Papua New Guinea, and the totality of available evidence derives from ethnobotanical reports and preclinical alkaloid characterization studies.
CategoryHerb
GroupPacific Islands
Evidence LevelPreliminary
Primary Keywordmuru pungu benefits
Muru Pungu — botanical close-up
Health Benefits
**Wound Healing (Ethnobotanical)**
Papua New Guinean traditional practitioners reportedly apply preparations of the plant to wounds; the biological basis may involve tannins and polyphenols such as leucoanthocyanins with mild astringent and antimicrobial activity, though no controlled evidence exists.
**Psychoactive Ritual Use**
Nasal insufflation of powdered seeds produces rapid visionary states lasting 15–30 minutes, mediated by bufotenin's agonism at 5-HT2A receptors, historically used for divination, healing ceremonies, and inter-tribal communication.
**Potential Antioxidant Activity**
Minor leaf constituents including orientin (a flavone C-glycoside) and catechol possess documented free-radical scavenging capacity in related plant systems; direct antioxidant assays for A. peregrina tissue are limited to qualitative phytochemical screening.
**Antimicrobial Potential**
Bufotenin and other indole alkaloids have demonstrated broad antimicrobial properties in related tryptamine-containing species in vitro; no formal minimum inhibitory concentration data specific to A. peregrina are published.
**Vasoconstrictive Effects**
Bufotenin interacts with peripheral 5-HT receptors on vascular smooth muscle, producing transient vasoconstriction, which may partially explain traditional topical use on bleeding wounds as a hemostatic adjunct.
**Anxiolytic/Ritual Catharsis (Traditional Context)**
Ritual insufflation is described by indigenous practitioners as therapeutically releasing; serotonergic modulation of limbic circuits provides a plausible neurobiological mechanism, though this framing is anthropological rather than clinical.
Origin & History
Natural habitat
Anadenanthera peregrina is native to tropical South America and the Caribbean, thriving in savanna woodlands, dry forests, and gallery forests across Venezuela, Brazil, Colombia, Argentina, and the Lesser Antilles. The tree grows to 20 meters in height and tolerates seasonally dry, well-drained soils at low to mid-elevations. It has been utilized by indigenous Amazonian and Caribbean peoples for millennia, harvested primarily from wild populations, with limited formal cultivation.
“Anadenanthera peregrina has one of the longest-documented histories of psychoactive plant use in the Americas, with archaeological evidence of cohoba snuff equipment found in Hispaniola dated to approximately 1000–1500 CE and references in early Spanish colonial accounts by Ramón Pané (1496) describing Taíno ceremonial use. South American indigenous groups including the Yanomami, Piaroa, Waiká, and various Orinoco basin peoples employ the seed powder—known variously as yopo, niopo, or cohoba—in shamanic healing rituals, inter-tribal negotiation, and communication with supernatural entities. The powdered seeds are insufflated through V-shaped bird-bone or bamboo tubes in a bilateral nasal insufflation ceremony often presided over by a shaman (hekura practitioner), with lime or ash added to enhance alkaloid freebasing and absorption. The secondary ethnobotanical record of wound application in Papua New Guinea represents a geographically distinct and pharmacologically separate folk use that has not been cross-validated with the primary Neotropical tradition.”Traditional Medicine
Scientific Research
No human clinical trials have been conducted on Anadenanthera peregrina for any therapeutic indication, including wound healing. Alkaloid content has been rigorously characterized via GC-MS and HPLC in multiple analytical studies confirming bufotenin concentrations up to 74 mg/g in seeds and DMT up to 1.6 mg/g; these are chemical characterization studies, not efficacy trials. Ethnopharmacological surveys document the Papua New Guinean wound-healing application as a secondary regional use distinct from the primary South American hallucinogenic tradition, but provide no outcome data, comparator groups, or mechanistic validation. The evidence base for any therapeutic claim is therefore pre-clinical and ethnobotanical in nature, and the ingredient receives a very low evidence score reflecting the complete absence of interventional human data.
Preparation & Dosage
Traditional preparation
**Traditional Snuff (South American)**
5 g of prepared powder delivers ~40 mg bufotenin when insufflated bilaterally through tubular applicators
Seeds are roasted, ground to fine powder, and mixed with alkaline lime, ash (Celtis sp.), or calcium hydroxide to freebase alkaloids; approximately 0..
**Wound Poultice (Papua New Guinean ethnobotanical)**
Bark or leaf material reportedly macerated and applied topically to wounds; no standardized preparation, concentration, or frequency has been documented in available sources.
**Effective Psychoactive Dose (Bufotenin)**
40–80 mg bufotenin via nasal insufflation; doses exceeding 100 mg insufflated carry significant cardiovascular and toxicological risk
~.
**DMT/5-MeO-DMT from seeds**
25 g powder) due to rapid MAO degradation and low seed concentrations; not a traditional delivery goal
Impractical as primary targets via seed snuff alone (would require >.
**Stability Note**
DMT and 5-MeO-DMT degrade substantially within 2 years in stored material; bufotenin is more stable; any preparation should account for alkaloid degradation in aged plant material.
**No Supplemental Form Established**
No commercial supplement, standardized extract, capsule, or nutraceutical formulation is recognized or approved for this ingredient.
Nutritional Profile
Anadenanthera peregrina is not consumed as a food and has no established nutritional profile as a dietary ingredient. Seeds are predominantly composed of protein, fatty acids, and carbohydrates typical of leguminous seeds, but exact macronutrient ratios are not reported in peer-reviewed literature for this species. Key phytochemicals by tissue: seeds contain bufotenin (~74 mg/g), DMT (~1.6 mg/g), 5-MeO-DMT (~0.4 mg/g), bufotenin N-oxide, and DMT N-oxide; bark contains N-methyltryptamine, 5-MeO-DMT, and DMT at trace levels; leaves contain catechol, leucoanthocyanin, and orientin (a flavone C-glycoside with documented antioxidant activity in other species). Bufotenin bioavailability is high via nasal mucosa (~60–80% estimated) but negligible via oral route due to first-pass MAO metabolism. No micronutrient data (vitamins, minerals) specific to this species are available in current literature.
How It Works
Mechanism of Action
The primary bioactive alkaloids—bufotenin (5-hydroxy-N,N-dimethyltryptamine), DMT, and 5-MeO-DMT—are structural analogs of serotonin that act as full or partial agonists at 5-HT2A receptors in cortical and subcortical brain regions, disrupting default mode network activity and producing altered states of consciousness; bufotenin additionally binds 5-HT1A, 5-HT2B, 5-HT2C, and sigma-1 receptors. Peripheral 5-HT2B and 5-HT3 receptor activation by bufotenin mediates the intense nausea and transient cardiovascular effects (tachycardia, hypertension, facial flushing) observed at higher doses during insufflation. DMT and 5-MeO-DMT are rapidly degraded by monoamine oxidase-A (MAO-A) in the nasal and gut mucosa, severely limiting their systemic bioavailability unless co-administered with MAO inhibitors; bufotenin is comparatively MAO-resistant due to its hydroxyl group, explaining its predominance in nasal absorption. Minor polyphenolic constituents (catechol, leucoanthocyanin) may modulate local oxidative and inflammatory processes at wound sites through non-specific free-radical quenching and protein precipitation, consistent with astringent wound-care applications.
Clinical Evidence
No registered clinical trials exist for Anadenanthera peregrina or its isolated alkaloids in the context of wound management or any other medical indication as of current literature. The wound-healing use attributed to Papua New Guinean tradition is documented solely in ethnobotanical field surveys, with no sample sizes, outcome measures, or control conditions reported. In vitro cytotoxicity and antihyperglycemic data cited in some databases pertain to the unrelated species Moringa peregrina and should not be extrapolated to this plant. Confidence in any therapeutic efficacy claim for muru pungu must be considered extremely low in the absence of even preliminary open-label human studies.
Safety & Interactions
Nasal insufflation of bufotenin-rich seed powder at doses exceeding 100 mg produces severe cardiovascular stress including hypertension, tachycardia, intense peripheral vasoconstriction, facial erythema, and profound nausea; cardiovascular fatalities have not been formally attributed to the plant but remain a theoretical concern given its serotonergic vasoactive profile. Co-administration with monoamine oxidase inhibitors (MAOIs, including pharmaceutical phenelzine, tranylcypromine, or herbal Syrian rue/Peganum harmala) would potentiate DMT and 5-MeO-DMT activity, dramatically amplifying psychoactive and cardiovascular risks. Contraindications include personal or family history of psychotic disorders, bipolar disorder, cardiovascular disease, hypertension, or concurrent use of serotonergic medications (SSRIs, SNRIs, triptans, lithium), given the risk of serotonin syndrome. No pregnancy or lactation safety data exist; the presence of potent psychoactive alkaloids with vasoconstrictive properties makes use during pregnancy categorically inadvisable, and no maximum safe dose has been established through formal toxicological assessment.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Anadenanthera peregrinaPiptadenia peregrinaYopoCohobaNiopoCebilHisioma
Frequently Asked Questions
What is muru pungu used for in traditional medicine?
In Papua New Guinea, muru pungu (Anadenanthera peregrina / Piptadenia peregrina) is reportedly applied to wounds as a topical preparation, though the precise method and active compounds responsible have not been scientifically validated. Separately, in its native South American and Caribbean range, the seeds have been used for millennia as a ritual hallucinogenic snuff known as yopo or cohoba, containing bufotenin, DMT, and 5-MeO-DMT. These two traditions are geographically and pharmacologically distinct.
What are the main active compounds in muru pungu seeds?
The seeds of Anadenanthera peregrina contain primarily bufotenin (5-hydroxy-DMT) at concentrations up to 74 mg per gram of dried seed material, making it the dominant alkaloid. Smaller amounts of DMT (up to 1.6 mg/g) and 5-MeO-DMT (up to 0.4 mg/g) are also present, along with their N-oxide derivatives. All three compounds are tryptamine alkaloids that act as serotonin 5-HT2A receptor agonists.
Is muru pungu (yopo) safe to use?
Muru pungu carries significant safety risks: bufotenin doses above approximately 100 mg via nasal insufflation produce intense cardiovascular stress, including hypertension and tachycardia, and the plant is contraindicated in individuals with heart disease, psychotic disorders, or those taking serotonergic medications due to risk of serotonin syndrome. No long-term safety data, established therapeutic dose, or regulatory approval exists for any medicinal application. Its psychoactive alkaloids are controlled substances in many jurisdictions.
Are there any clinical trials supporting the wound-healing use of muru pungu?
No clinical trials of any design have been conducted on Anadenanthera peregrina for wound healing or any other therapeutic application. The Papua New Guinean wound-care use is documented exclusively in ethnobotanical field surveys without outcome data, controls, or mechanistic studies. Until controlled human research is conducted, the wound-healing claim remains anecdotal.
How was yopo (muru pungu) traditionally prepared and used?
In South American indigenous tradition, the seeds were first roasted, then ground to a fine powder and mixed with an alkaline substance such as wood ash or calcium hydroxide (lime) to convert the alkaloid salts to absorbable free-base forms. The resulting powder was then insufflated bilaterally through the nostrils using a V-shaped tube made from bird bone or bamboo, typically in a ceremonial context overseen by a shaman. The lime-mixing step is pharmacologically essential, as it significantly increases bufotenin bioavailability through the nasal mucosa.
Does muru pungu interact with psychiatric medications or SSRIs?
Muru pungu contains compounds with psychoactive properties and potential serotonergic activity, raising theoretical concerns about interactions with SSRIs and other psychiatric medications. No formal drug interaction studies exist for this ingredient, making concurrent use with psychiatric drugs inadvisable without professional medical supervision. Anyone taking antidepressants or anti-anxiety medications should consult a healthcare provider before using muru pungu in any form.
Is muru pungu safe for pregnant or breastfeeding women?
There is insufficient safety data on muru pungu use during pregnancy or lactation, and its psychoactive alkaloids raise potential concerns for fetal development and nursing infants. Traditional use does not establish safety in these vulnerable populations. Pregnant and breastfeeding women should avoid muru pungu entirely and consult a healthcare provider if considering any preparation of this plant.
What is the difference between the wound-healing and ritual uses of muru pungu, and are they related to different plant parts?
Traditional wound-healing applications in Papua New Guinea typically involve topical paste preparations applied to skin injuries, likely utilizing tannins and polyphenols in the plant material. In contrast, ritual psychoactive use involves nasal insufflation of powdered seeds, which deliver alkaloids (particularly N,N-DMT and related compounds) into the bloodstream for visionary effects. These represent distinct ethnobotanical applications exploiting different plant constituents and administration routes.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w muru-pungu-anadenanthera-peregrina-piptadenia-peregrina curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
